Global Small Molecule Drug CDMO Market Growth (Status and Outlook) 2026-2032
The global Small Molecule Drug CDMO market size is predicted to grow from US$ 31980 million in 2025 to US$ 48100 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Small Molecule Drug CDMO Industry Forecast” looks at past sales and reviews total world Small Molecule Drug CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Molecule Drug CDMO sales for 2026 through 2032. With Small Molecule Drug CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Drug CDMO industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Drug CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Drug CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Drug CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Drug CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Drug CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Drug CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Small Molecule Drug CDMO Industry Forecast” looks at past sales and reviews total world Small Molecule Drug CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Molecule Drug CDMO sales for 2026 through 2032. With Small Molecule Drug CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Drug CDMO industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Drug CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Drug CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Drug CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Drug CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Drug CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Drug CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- FDF CDMO
- Packaging CDMO
- Clinical CDMO
- Pharmaceutical Company
- Biotechnology Company
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- FUJIFILM Diosynth Biotechnologies
- Asymchem
- Pfizer CentreOne
- Delpharm
- Recipharm
- AGC Pharma Chemicals
- Boehringer Ingelheim
- Vetter
- Curia
- Aenova
- Porton
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Molecule Drug CDMO Market Size (2021-2032)
2.1.2 Small Molecule Drug CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Molecule Drug CDMO by Country/Region (2021, 2025 & 2032)
2.2 Small Molecule Drug CDMO Segment by Type
2.2.1 FDF CDMO
2.2.2 Packaging CDMO
2.2.3 Clinical CDMO
2.2.4 Small Molecule Drug CDMO Market Size by Type
2.2.4.1 Small Molecule Drug CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
2.3 Small Molecule Drug CDMO Segment by Application
2.3.1 Pharmaceutical Company
2.3.2 Biotechnology Company
2.3.3 Other
2.3.4 Small Molecule Drug CDMO Market Size by Application
2.3.4.1 Small Molecule Drug CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
3 SMALL MOLECULE DRUG CDMO MARKET SIZE BY PLAYER
3.1 Small Molecule Drug CDMO Market Size Market Share by Player
3.1.1 Global Small Molecule Drug CDMO Revenue by Player (2021-2026)
3.1.2 Global Small Molecule Drug CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Small Molecule Drug CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE DRUG CDMO BY REGION
4.1 Small Molecule Drug CDMO Market Size by Region (2021-2026)
4.2 Global Small Molecule Drug CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Molecule Drug CDMO Market Size Growth (2021-2026)
4.4 APAC Small Molecule Drug CDMO Market Size Growth (2021-2026)
4.5 Europe Small Molecule Drug CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Molecule Drug CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Molecule Drug CDMO Market Size by Country (2021-2026)
5.2 Americas Small Molecule Drug CDMO Market Size by Type (2021-2026)
5.3 Americas Small Molecule Drug CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Drug CDMO Market Size by Region (2021-2026)
6.2 APAC Small Molecule Drug CDMO Market Size by Type (2021-2026)
6.3 APAC Small Molecule Drug CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Molecule Drug CDMO Market Size by Country (2021-2026)
7.2 Europe Small Molecule Drug CDMO Market Size by Type (2021-2026)
7.3 Europe Small Molecule Drug CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Molecule Drug CDMO by Region (2021-2026)
8.2 Middle East & Africa Small Molecule Drug CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL MOLECULE DRUG CDMO MARKET FORECAST
10.1 Global Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.1.1 Global Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.1.2 Americas Small Molecule Drug CDMO Forecast
10.1.3 APAC Small Molecule Drug CDMO Forecast
10.1.4 Europe Small Molecule Drug CDMO Forecast
10.1.5 Middle East & Africa Small Molecule Drug CDMO Forecast
10.2 Americas Small Molecule Drug CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Small Molecule Drug CDMO Forecast
10.2.2 Canada Market Small Molecule Drug CDMO Forecast
10.2.3 Mexico Market Small Molecule Drug CDMO Forecast
10.2.4 Brazil Market Small Molecule Drug CDMO Forecast
10.3 APAC Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.3.1 China Small Molecule Drug CDMO Market Forecast
10.3.2 Japan Market Small Molecule Drug CDMO Forecast
10.3.3 Korea Market Small Molecule Drug CDMO Forecast
10.3.4 Southeast Asia Market Small Molecule Drug CDMO Forecast
10.3.5 India Market Small Molecule Drug CDMO Forecast
10.3.6 Australia Market Small Molecule Drug CDMO Forecast
10.4 Europe Small Molecule Drug CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Small Molecule Drug CDMO Forecast
10.4.2 France Market Small Molecule Drug CDMO Forecast
10.4.3 UK Market Small Molecule Drug CDMO Forecast
10.4.4 Italy Market Small Molecule Drug CDMO Forecast
10.4.5 Russia Market Small Molecule Drug CDMO Forecast
10.5 Middle East & Africa Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Molecule Drug CDMO Forecast
10.5.2 South Africa Market Small Molecule Drug CDMO Forecast
10.5.3 Israel Market Small Molecule Drug CDMO Forecast
10.5.4 Turkey Market Small Molecule Drug CDMO Forecast
10.6 Global Small Molecule Drug CDMO Forecast by Type (2027-2032)
10.7 Global Small Molecule Drug CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Molecule Drug CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Small Molecule Drug CDMO Product Offered
11.1.3 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Small Molecule Drug CDMO Product Offered
11.2.3 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Small Molecule Drug CDMO Product Offered
11.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Small Molecule Drug CDMO Product Offered
11.4.3 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Fareva
11.5.1 Fareva Company Information
11.5.2 Fareva Small Molecule Drug CDMO Product Offered
11.5.3 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fareva Main Business Overview
11.5.5 Fareva Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Small Molecule Drug CDMO Product Offered
11.6.3 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Information
11.7.2 WuXi Biologics Small Molecule Drug CDMO Product Offered
11.7.3 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi Biologics Main Business Overview
11.7.5 WuXi Biologics Latest Developments
11.8 Siegfried
11.8.1 Siegfried Company Information
11.8.2 Siegfried Small Molecule Drug CDMO Product Offered
11.8.3 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Siegfried Main Business Overview
11.8.5 Siegfried Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Small Molecule Drug CDMO Product Offered
11.10.3 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Small Molecule Drug CDMO Product Offered
11.11.3 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Small Molecule Drug CDMO Product Offered
11.12.3 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm Small Molecule Drug CDMO Product Offered
11.13.3 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Information
11.14.2 AGC Pharma Chemicals Small Molecule Drug CDMO Product Offered
11.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 AGC Pharma Chemicals Main Business Overview
11.14.5 AGC Pharma Chemicals Latest Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Information
11.15.2 Boehringer Ingelheim Small Molecule Drug CDMO Product Offered
11.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Boehringer Ingelheim Main Business Overview
11.15.5 Boehringer Ingelheim Latest Developments
11.16 Vetter
11.16.1 Vetter Company Information
11.16.2 Vetter Small Molecule Drug CDMO Product Offered
11.16.3 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Vetter Main Business Overview
11.16.5 Vetter Latest Developments
11.17 Curia
11.17.1 Curia Company Information
11.17.2 Curia Small Molecule Drug CDMO Product Offered
11.17.3 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Curia Main Business Overview
11.17.5 Curia Latest Developments
11.18 Aenova
11.18.1 Aenova Company Information
11.18.2 Aenova Small Molecule Drug CDMO Product Offered
11.18.3 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Aenova Main Business Overview
11.18.5 Aenova Latest Developments
11.19 Porton
11.19.1 Porton Company Information
11.19.2 Porton Small Molecule Drug CDMO Product Offered
11.19.3 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Porton Main Business Overview
11.19.5 Porton Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Molecule Drug CDMO Market Size (2021-2032)
2.1.2 Small Molecule Drug CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Molecule Drug CDMO by Country/Region (2021, 2025 & 2032)
2.2 Small Molecule Drug CDMO Segment by Type
2.2.1 FDF CDMO
2.2.2 Packaging CDMO
2.2.3 Clinical CDMO
2.2.4 Small Molecule Drug CDMO Market Size by Type
2.2.4.1 Small Molecule Drug CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
2.3 Small Molecule Drug CDMO Segment by Application
2.3.1 Pharmaceutical Company
2.3.2 Biotechnology Company
2.3.3 Other
2.3.4 Small Molecule Drug CDMO Market Size by Application
2.3.4.1 Small Molecule Drug CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
3 SMALL MOLECULE DRUG CDMO MARKET SIZE BY PLAYER
3.1 Small Molecule Drug CDMO Market Size Market Share by Player
3.1.1 Global Small Molecule Drug CDMO Revenue by Player (2021-2026)
3.1.2 Global Small Molecule Drug CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Small Molecule Drug CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE DRUG CDMO BY REGION
4.1 Small Molecule Drug CDMO Market Size by Region (2021-2026)
4.2 Global Small Molecule Drug CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Molecule Drug CDMO Market Size Growth (2021-2026)
4.4 APAC Small Molecule Drug CDMO Market Size Growth (2021-2026)
4.5 Europe Small Molecule Drug CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Molecule Drug CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Molecule Drug CDMO Market Size by Country (2021-2026)
5.2 Americas Small Molecule Drug CDMO Market Size by Type (2021-2026)
5.3 Americas Small Molecule Drug CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Drug CDMO Market Size by Region (2021-2026)
6.2 APAC Small Molecule Drug CDMO Market Size by Type (2021-2026)
6.3 APAC Small Molecule Drug CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Molecule Drug CDMO Market Size by Country (2021-2026)
7.2 Europe Small Molecule Drug CDMO Market Size by Type (2021-2026)
7.3 Europe Small Molecule Drug CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Molecule Drug CDMO by Region (2021-2026)
8.2 Middle East & Africa Small Molecule Drug CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL MOLECULE DRUG CDMO MARKET FORECAST
10.1 Global Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.1.1 Global Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.1.2 Americas Small Molecule Drug CDMO Forecast
10.1.3 APAC Small Molecule Drug CDMO Forecast
10.1.4 Europe Small Molecule Drug CDMO Forecast
10.1.5 Middle East & Africa Small Molecule Drug CDMO Forecast
10.2 Americas Small Molecule Drug CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Small Molecule Drug CDMO Forecast
10.2.2 Canada Market Small Molecule Drug CDMO Forecast
10.2.3 Mexico Market Small Molecule Drug CDMO Forecast
10.2.4 Brazil Market Small Molecule Drug CDMO Forecast
10.3 APAC Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.3.1 China Small Molecule Drug CDMO Market Forecast
10.3.2 Japan Market Small Molecule Drug CDMO Forecast
10.3.3 Korea Market Small Molecule Drug CDMO Forecast
10.3.4 Southeast Asia Market Small Molecule Drug CDMO Forecast
10.3.5 India Market Small Molecule Drug CDMO Forecast
10.3.6 Australia Market Small Molecule Drug CDMO Forecast
10.4 Europe Small Molecule Drug CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Small Molecule Drug CDMO Forecast
10.4.2 France Market Small Molecule Drug CDMO Forecast
10.4.3 UK Market Small Molecule Drug CDMO Forecast
10.4.4 Italy Market Small Molecule Drug CDMO Forecast
10.4.5 Russia Market Small Molecule Drug CDMO Forecast
10.5 Middle East & Africa Small Molecule Drug CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Molecule Drug CDMO Forecast
10.5.2 South Africa Market Small Molecule Drug CDMO Forecast
10.5.3 Israel Market Small Molecule Drug CDMO Forecast
10.5.4 Turkey Market Small Molecule Drug CDMO Forecast
10.6 Global Small Molecule Drug CDMO Forecast by Type (2027-2032)
10.7 Global Small Molecule Drug CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Molecule Drug CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Small Molecule Drug CDMO Product Offered
11.1.3 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Small Molecule Drug CDMO Product Offered
11.2.3 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Small Molecule Drug CDMO Product Offered
11.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Small Molecule Drug CDMO Product Offered
11.4.3 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Fareva
11.5.1 Fareva Company Information
11.5.2 Fareva Small Molecule Drug CDMO Product Offered
11.5.3 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fareva Main Business Overview
11.5.5 Fareva Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Small Molecule Drug CDMO Product Offered
11.6.3 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Information
11.7.2 WuXi Biologics Small Molecule Drug CDMO Product Offered
11.7.3 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi Biologics Main Business Overview
11.7.5 WuXi Biologics Latest Developments
11.8 Siegfried
11.8.1 Siegfried Company Information
11.8.2 Siegfried Small Molecule Drug CDMO Product Offered
11.8.3 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Siegfried Main Business Overview
11.8.5 Siegfried Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Small Molecule Drug CDMO Product Offered
11.10.3 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Small Molecule Drug CDMO Product Offered
11.11.3 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Small Molecule Drug CDMO Product Offered
11.12.3 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm Small Molecule Drug CDMO Product Offered
11.13.3 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Information
11.14.2 AGC Pharma Chemicals Small Molecule Drug CDMO Product Offered
11.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 AGC Pharma Chemicals Main Business Overview
11.14.5 AGC Pharma Chemicals Latest Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Information
11.15.2 Boehringer Ingelheim Small Molecule Drug CDMO Product Offered
11.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Boehringer Ingelheim Main Business Overview
11.15.5 Boehringer Ingelheim Latest Developments
11.16 Vetter
11.16.1 Vetter Company Information
11.16.2 Vetter Small Molecule Drug CDMO Product Offered
11.16.3 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Vetter Main Business Overview
11.16.5 Vetter Latest Developments
11.17 Curia
11.17.1 Curia Company Information
11.17.2 Curia Small Molecule Drug CDMO Product Offered
11.17.3 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Curia Main Business Overview
11.17.5 Curia Latest Developments
11.18 Aenova
11.18.1 Aenova Company Information
11.18.2 Aenova Small Molecule Drug CDMO Product Offered
11.18.3 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Aenova Main Business Overview
11.18.5 Aenova Latest Developments
11.19 Porton
11.19.1 Porton Company Information
11.19.2 Porton Small Molecule Drug CDMO Product Offered
11.19.3 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Porton Main Business Overview
11.19.5 Porton Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Small Molecule Drug CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Molecule Drug CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of FDF CDMO
Table 4. Major Players of Packaging CDMO
Table 5. Major Players of Clinical CDMO
Table 6. Small Molecule Drug CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Table 9. Small Molecule Drug CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Table 12. Global Small Molecule Drug CDMO Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Small Molecule Drug CDMO Revenue Market Share by Player (2021-2026)
Table 14. Small Molecule Drug CDMO Key Players Head office and Products Offered
Table 15. Small Molecule Drug CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Molecule Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Table 20. Global Small Molecule Drug CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Small Molecule Drug CDMO Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Small Molecule Drug CDMO Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Small Molecule Drug CDMO Market Size Market Share by Country (2021-2026)
Table 24. Americas Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Table 26. Americas Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Table 28. APAC Small Molecule Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Table 30. APAC Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Small Molecule Drug CDMO Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Small Molecule Drug CDMO Market Size Market Share by Country (2021-2026)
Table 34. Europe Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Molecule Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Molecule Drug CDMO
Table 40. Key Market Challenges & Risks of Small Molecule Drug CDMO
Table 41. Key Industry Trends of Small Molecule Drug CDMO
Table 42. Global Small Molecule Drug CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Small Molecule Drug CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Small Molecule Drug CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Lonza Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 47. Lonza Small Molecule Drug CDMO Product Offered
Table 48. Lonza Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Lonza Main Business
Table 50. Lonza Latest Developments
Table 51. Catalent Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 52. Catalent Small Molecule Drug CDMO Product Offered
Table 53. Catalent Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Catalent Main Business
Table 55. Catalent Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Small Molecule Drug CDMO Product Offered
Table 58. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Samsung Biologics Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 62. Samsung Biologics Small Molecule Drug CDMO Product Offered
Table 63. Samsung Biologics Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Samsung Biologics Main Business
Table 65. Samsung Biologics Latest Developments
Table 66. Fareva Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 67. Fareva Small Molecule Drug CDMO Product Offered
Table 68. Fareva Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Fareva Main Business
Table 70. Fareva Latest Developments
Table 71. WuXi AppTech Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 72. WuXi AppTech Small Molecule Drug CDMO Product Offered
Table 73. WuXi AppTech Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. WuXi AppTech Main Business
Table 75. WuXi AppTech Latest Developments
Table 76. WuXi Biologics Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 77. WuXi Biologics Small Molecule Drug CDMO Product Offered
Table 78. WuXi Biologics Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. WuXi Biologics Main Business
Table 80. WuXi Biologics Latest Developments
Table 81. Siegfried Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 82. Siegfried Small Molecule Drug CDMO Product Offered
Table 83. Siegfried Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Siegfried Main Business
Table 85. Siegfried Latest Developments
Table 86. FUJIFILM Diosynth Biotechnologies Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 87. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Offered
Table 88. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. FUJIFILM Diosynth Biotechnologies Main Business
Table 90. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 91. Asymchem Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 92. Asymchem Small Molecule Drug CDMO Product Offered
Table 93. Asymchem Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Asymchem Main Business
Table 95. Asymchem Latest Developments
Table 96. Pfizer CentreOne Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product Offered
Table 98. Pfizer CentreOne Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Pfizer CentreOne Main Business
Table 100. Pfizer CentreOne Latest Developments
Table 101. Delpharm Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 102. Delpharm Small Molecule Drug CDMO Product Offered
Table 103. Delpharm Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Delpharm Main Business
Table 105. Delpharm Latest Developments
Table 106. Recipharm Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 107. Recipharm Small Molecule Drug CDMO Product Offered
Table 108. Recipharm Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Recipharm Main Business
Table 110. Recipharm Latest Developments
Table 111. AGC Pharma Chemicals Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 112. AGC Pharma Chemicals Small Molecule Drug CDMO Product Offered
Table 113. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AGC Pharma Chemicals Main Business
Table 115. AGC Pharma Chemicals Latest Developments
Table 116. Boehringer Ingelheim Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 117. Boehringer Ingelheim Small Molecule Drug CDMO Product Offered
Table 118. Boehringer Ingelheim Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Boehringer Ingelheim Main Business
Table 120. Boehringer Ingelheim Latest Developments
Table 121. Vetter Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 122. Vetter Small Molecule Drug CDMO Product Offered
Table 123. Vetter Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Vetter Main Business
Table 125. Vetter Latest Developments
Table 126. Curia Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 127. Curia Small Molecule Drug CDMO Product Offered
Table 128. Curia Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Curia Main Business
Table 130. Curia Latest Developments
Table 131. Aenova Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 132. Aenova Small Molecule Drug CDMO Product Offered
Table 133. Aenova Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Aenova Main Business
Table 135. Aenova Latest Developments
Table 136. Porton Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 137. Porton Small Molecule Drug CDMO Product Offered
Table 138. Porton Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Porton Main Business
Table 140. Porton Latest Developments
Table 1. Small Molecule Drug CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Molecule Drug CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of FDF CDMO
Table 4. Major Players of Packaging CDMO
Table 5. Major Players of Clinical CDMO
Table 6. Small Molecule Drug CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Table 9. Small Molecule Drug CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Table 12. Global Small Molecule Drug CDMO Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Small Molecule Drug CDMO Revenue Market Share by Player (2021-2026)
Table 14. Small Molecule Drug CDMO Key Players Head office and Products Offered
Table 15. Small Molecule Drug CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Molecule Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Table 20. Global Small Molecule Drug CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Small Molecule Drug CDMO Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Small Molecule Drug CDMO Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Small Molecule Drug CDMO Market Size Market Share by Country (2021-2026)
Table 24. Americas Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Table 26. Americas Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Table 28. APAC Small Molecule Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Table 30. APAC Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Small Molecule Drug CDMO Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Small Molecule Drug CDMO Market Size Market Share by Country (2021-2026)
Table 34. Europe Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Molecule Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Molecule Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Small Molecule Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Molecule Drug CDMO
Table 40. Key Market Challenges & Risks of Small Molecule Drug CDMO
Table 41. Key Industry Trends of Small Molecule Drug CDMO
Table 42. Global Small Molecule Drug CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Small Molecule Drug CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Small Molecule Drug CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Lonza Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 47. Lonza Small Molecule Drug CDMO Product Offered
Table 48. Lonza Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Lonza Main Business
Table 50. Lonza Latest Developments
Table 51. Catalent Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 52. Catalent Small Molecule Drug CDMO Product Offered
Table 53. Catalent Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Catalent Main Business
Table 55. Catalent Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Small Molecule Drug CDMO Product Offered
Table 58. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Samsung Biologics Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 62. Samsung Biologics Small Molecule Drug CDMO Product Offered
Table 63. Samsung Biologics Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Samsung Biologics Main Business
Table 65. Samsung Biologics Latest Developments
Table 66. Fareva Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 67. Fareva Small Molecule Drug CDMO Product Offered
Table 68. Fareva Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Fareva Main Business
Table 70. Fareva Latest Developments
Table 71. WuXi AppTech Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 72. WuXi AppTech Small Molecule Drug CDMO Product Offered
Table 73. WuXi AppTech Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. WuXi AppTech Main Business
Table 75. WuXi AppTech Latest Developments
Table 76. WuXi Biologics Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 77. WuXi Biologics Small Molecule Drug CDMO Product Offered
Table 78. WuXi Biologics Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. WuXi Biologics Main Business
Table 80. WuXi Biologics Latest Developments
Table 81. Siegfried Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 82. Siegfried Small Molecule Drug CDMO Product Offered
Table 83. Siegfried Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Siegfried Main Business
Table 85. Siegfried Latest Developments
Table 86. FUJIFILM Diosynth Biotechnologies Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 87. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Offered
Table 88. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. FUJIFILM Diosynth Biotechnologies Main Business
Table 90. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 91. Asymchem Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 92. Asymchem Small Molecule Drug CDMO Product Offered
Table 93. Asymchem Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Asymchem Main Business
Table 95. Asymchem Latest Developments
Table 96. Pfizer CentreOne Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product Offered
Table 98. Pfizer CentreOne Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Pfizer CentreOne Main Business
Table 100. Pfizer CentreOne Latest Developments
Table 101. Delpharm Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 102. Delpharm Small Molecule Drug CDMO Product Offered
Table 103. Delpharm Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Delpharm Main Business
Table 105. Delpharm Latest Developments
Table 106. Recipharm Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 107. Recipharm Small Molecule Drug CDMO Product Offered
Table 108. Recipharm Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Recipharm Main Business
Table 110. Recipharm Latest Developments
Table 111. AGC Pharma Chemicals Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 112. AGC Pharma Chemicals Small Molecule Drug CDMO Product Offered
Table 113. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AGC Pharma Chemicals Main Business
Table 115. AGC Pharma Chemicals Latest Developments
Table 116. Boehringer Ingelheim Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 117. Boehringer Ingelheim Small Molecule Drug CDMO Product Offered
Table 118. Boehringer Ingelheim Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Boehringer Ingelheim Main Business
Table 120. Boehringer Ingelheim Latest Developments
Table 121. Vetter Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 122. Vetter Small Molecule Drug CDMO Product Offered
Table 123. Vetter Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Vetter Main Business
Table 125. Vetter Latest Developments
Table 126. Curia Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 127. Curia Small Molecule Drug CDMO Product Offered
Table 128. Curia Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Curia Main Business
Table 130. Curia Latest Developments
Table 131. Aenova Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 132. Aenova Small Molecule Drug CDMO Product Offered
Table 133. Aenova Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Aenova Main Business
Table 135. Aenova Latest Developments
Table 136. Porton Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
Table 137. Porton Small Molecule Drug CDMO Product Offered
Table 138. Porton Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Porton Main Business
Table 140. Porton Latest Developments
LIST OF FIGURES
Figure 1. Small Molecule Drug CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Drug CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Molecule Drug CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Molecule Drug CDMO Sales Market Share by Country/Region (2025)
Figure 8. Small Molecule Drug CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Molecule Drug CDMO Market Size Market Share by Type in 2025
Figure 10. Small Molecule Drug CDMO in Pharmaceutical Company
Figure 11. Global Small Molecule Drug CDMO Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 12. Small Molecule Drug CDMO in Biotechnology Company
Figure 13. Global Small Molecule Drug CDMO Market: Biotechnology Company (2021-2026) & ($ millions)
Figure 14. Small Molecule Drug CDMO in Other
Figure 15. Global Small Molecule Drug CDMO Market: Other (2021-2026) & ($ millions)
Figure 16. Global Small Molecule Drug CDMO Market Size Market Share by Application in 2025
Figure 17. Global Small Molecule Drug CDMO Revenue Market Share by Player in 2025
Figure 18. Global Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas Small Molecule Drug CDMO Value Market Share by Country in 2025
Figure 24. United States Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Small Molecule Drug CDMO Market Size Market Share by Region in 2025
Figure 29. APAC Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Small Molecule Drug CDMO Market Size Market Share by Country in 2025
Figure 38. Europe Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 61. China Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 65. India Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 68. France Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 1. Small Molecule Drug CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Drug CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Molecule Drug CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Molecule Drug CDMO Sales Market Share by Country/Region (2025)
Figure 8. Small Molecule Drug CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Molecule Drug CDMO Market Size Market Share by Type in 2025
Figure 10. Small Molecule Drug CDMO in Pharmaceutical Company
Figure 11. Global Small Molecule Drug CDMO Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 12. Small Molecule Drug CDMO in Biotechnology Company
Figure 13. Global Small Molecule Drug CDMO Market: Biotechnology Company (2021-2026) & ($ millions)
Figure 14. Small Molecule Drug CDMO in Other
Figure 15. Global Small Molecule Drug CDMO Market: Other (2021-2026) & ($ millions)
Figure 16. Global Small Molecule Drug CDMO Market Size Market Share by Application in 2025
Figure 17. Global Small Molecule Drug CDMO Revenue Market Share by Player in 2025
Figure 18. Global Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Small Molecule Drug CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas Small Molecule Drug CDMO Value Market Share by Country in 2025
Figure 24. United States Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Small Molecule Drug CDMO Market Size Market Share by Region in 2025
Figure 29. APAC Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Small Molecule Drug CDMO Market Size Market Share by Country in 2025
Figure 38. Europe Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Small Molecule Drug CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 61. China Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 65. India Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 68. France Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Small Molecule Drug CDMO Market Size 2027-2032 ($ millions)
